Ramucirumab Drug Interactions
Currently displaying a list of 143 drugs known to interact with ramucirumab.
- 100 major drug interactions
- 43 moderate drug interactions
Medications known to interact with ramucirumab
Note: Showing generic names only.
- abciximab
- acalabrutinib
- ado-trastuzumab emtansine
- alteplase
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
- cabozantinib
- cangrelor
- caplacizumab
- choline salicylate
- cilostazol
- citalopram
- clomipramine
- clopidogrel
- dabigatran
- dalteparin
- danaparoid
- daprodustat
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dimethyl fumarate
- dipyridamole
- diroximel fumarate
- drotrecogin alfa
- duloxetine
- edoxaban
- efgartigimod alfa
- encorafenib
- enoxaparin
- epoprostenol
- eptifibatide
- erlotinib
- escitalopram
- etodolac
- faricimab ophthalmic
- fedratinib
- fenfluramine
- fenoprofen
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- panobinostat
- paroxetine
- pentosan polysulfate sodium
- phenylbutazone
- piroxicam
- plicamycin
- ponatinib
- prasugrel
- salsalate
- sertraline
- sibutramine
- sodium salicylate
- sodium thiosalicylate
- streptokinase
- sulfinpyrazone
- sulindac
- suprofen ophthalmic
- tazemetostat
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
Ramucirumab disease interactions
There are 8 disease interactions with ramucirumab which include:
- bleeding
- GI perforation
- hypothyroidism
- liver dysfunction
- hypertension
- PRES
- proteinuria
- thromboembolic disorders
Report options
More about ramucirumab
- ramucirumab consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Gemcitabine
Gemcitabine is used for breast cancer, breast cancer, metastatic, nasopharyngeal carcinoma, non ...
Nivolumab
Nivolumab is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Paclitaxel
Paclitaxel is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, kaposi's ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
